Daniel MacDonald is an experienced Associate Consultant Health Economist at Mtech Access since August 2020, specializing in global oncology model building and adaptations for HTA submissions, including NICE and CADTH submissions. Daniel has a proven track record in surrogate endpoint validation analyses, the development of commercial budget impact models, and leading economic sections in advisory boards. Prior to this role, Daniel worked as a Senior Health Economist and Health Economist at Wickenstones Ltd from October 2017 to August 2020, focusing on health economics, organizational and pricing strategies, and modeling. Daniel also gained experience as a Placement Student at The Health Foundation, analyzing the impact of anti-smoking legislation in OECD countries for a master's dissertation. Educational background includes a Master's degree in Health Economics and a BSc in Economics, both from the University of York.